ARLINGTON, Va., Sept. 19, 2019 /PRNewswire/ -- On Monday, September 23—the first day of fall—the National Council on Aging (NCOA) is partnering with thousands of educators, caregivers, health and aging

MINNEAPOLIS, Sept. 19, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO; OTCQX: VREOF), a leading science-focused, multi-state cannabis company, today announced that its shares have received Depository Trust Company (DTC) full-service eligibility in the United States.

DALLAS, Sept. 19, 2019 /PRNewswire/ -- Dallas-based MedCore Partners recently added two members to its Senior Living team amidst the continued growth of its seniors housing platform.

PASADENA, Calif., Sept. 19, 2019 /PRNewswire/ -- The world-class surgeons at Eyesthetica have been featured in Pasadena Magazine, honored among the top health practitioners of 2019. As the largest oculofacial surgery practice dedicated to eyelid and facial surgery in the Los Angeles area, Eyesthetica promises patients natural-looking, youthful, and re

INDIANAPOLIS, Sept. 19, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will conduct a webcast on Wednesday, October 2, 2019 to discuss the company's presentations at the 2019 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain. Remarks will focus primarily on data being pres

WARSAW, Ind., Sept. 19, 2019 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced a multinational distribution agreement with Align Technology, Inc. (NASDAQ: ALGN), for the award-winning iTero Element family of intraoral scanners. Terms of the agreement have not been disclosed. The agreement expa

SECAUCUS, N.J., Sept. 19, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has received the 2019 Best Employers: Excellence in Health & Well-Being award, presented by the National Business Group on Health, a non-profit association of more than 440 large U.S. employer

BOSTON, Sept.19, 2019 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and other diseases caused by dysfunctional protein processing, today announced that Proteostasis management will present at the UK Cystic Fibrosis Conference (UKCFC) on

TORRANCE, Calif., Sept. 19, 2019 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTC: EMMA), a leader in sickle cell disease treatment, today announced the withdrawal of its marketing authorization application (MAA) to the European Medicines Agency (EMA) for Xyndari™ (glutamine) for the treatment of sickle cell disease.Xyndari was approved under the

CHICAGO, Sept. 19, 2019 /PRNewswire/ -- Hillrom (NYSE: HRC), will host its fiscal fourth quarter 2019 earnings conference call and webcast on Friday, November 1, 2019, beginning at 7:00 a.m. (CT) / 8:00 a.m. (ET).